Timothy P. Noyes net worth and biography

Timothy Noyes Biography and Net Worth

Timothy Noyes is the CEO of Aerovate Therapeutics.

What is Timothy P. Noyes' net worth?: The estimated net worth of Timothy P. Noyes is at least $228.00 as of May 1st, 2023. Noyes owns 19 shares of Aerovate Therapeutics stock worth more than $228 as of December 5th. This net worth estimate does not reflect any other investments that Noyes may own. Additionally, Noyes receives a salary of $936,900.00 as CEO at Aerovate Therapeutics. Learn More about Timothy P. Noyes' net worth.
How old is Timothy P. Noyes?: Noyes is currently 62 years old. There are 6 older executives and no younger executives at Aerovate Therapeutics. Learn More on Timothy P. Noyes' age.
What is Timothy P. Noyes' salary?: As the CEO of Aerovate Therapeutics, Inc., Noyes earns $936,900.00 per year. Learn More on Timothy P. Noyes' salary.
How do I contact Timothy P. Noyes?: The corporate mailing address for Noyes and other Aerovate Therapeutics executives is , , . Aerovate Therapeutics can also be reached via phone at 617-443-2400 and via email at [email protected]. Learn More on Timothy P. Noyes' contact information.
Has Timothy P. Noyes been buying or selling shares of Aerovate Therapeutics?: Timothy P. Noyes has not been actively trading shares of Aerovate Therapeutics during the past quarter. Learn More on Timothy P. Noyes' trading history.
Who are Aerovate Therapeutics' active insiders?: Aerovate Therapeutics' insider roster includes Benjamin Dake (Insider), cormorant Lp (Insider), and Timothy Noyes (CEO). Learn More on Aerovate Therapeutics' active insiders.

Timothy P. Noyes Insider Trading History at Aerovate Therapeutics

Timothy P. Noyes Buying and Selling Activity at Aerovate Therapeutics

Aerovate Therapeutics Company Overview

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $12.00

$11.32

$12.40

50 Day Range

MA: $10.13

$8.06

$12.82

2 Week Range

Now: $12.00

$56.35

$105.00

Volume

246,525 shs

Average Volume

12,438 shs

Market Capitalization

$347.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Timothy Noyes Biography and Net Worth

What is Timothy P. Noyes' net worth?

How old is Timothy P. Noyes?

What is Timothy P. Noyes' salary?

How do I contact Timothy P. Noyes?

Has Timothy P. Noyes been buying or selling shares of Aerovate Therapeutics?

Who are Aerovate Therapeutics' active insiders?